Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
Reviewers:
(1) Jyoti Dattatray Anap, Dr. Kolpe Institute of Pharmacy Kolpewadi, India.
(2) Ravindra M Hanwate, DBATU, India.
(3) OP Agrawal, Bhabha Pharmacy Research Institute, Bhabha University, India.
Additional Reviewers:
(1) Suneeta Panicker, Savitribai Phule Pune University, India.
(2) Deepa K, Mercy College Palakkad, India.
(3) Kundan J. Tiwari, SMBT Institute of D. Pharmacy, India.
(4) Mohit pal, Udttrakhand Technical University, India.
(5) Ranjeet Kumar Ranjan, Ranchi University, India.
(6) Ronke Hadiyat Bello, University of Ilorin, Nigeria.
(7) S. Ramesh Babu, Mepco Schlenk Engineering College, India.
(8) Xiang Cai, Comenius University Bratislava, Slovakia.
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (Jyoti Dattatray Anap, India) | File 1 | NA
Stage 2 | Peer Review Report_2 (Ravindra M Hanwate, India) | File 1 | NA
Stage 2 | Peer Review Report_3 (OP Agrawal, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA